Life Science Analytics Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC535

Introduction

Life science analytics helps healthcare organizations to overcome challenges such as to be more cost efficient, patient centric and improve the services or products. Life science analytics also helps to derive decisions on the product positioning and planning. The market for life science analytics is expected to grow due to increasing demand for standardization of data, availability of big data in life science industry, and greater application of analytical solutions in healthcare industry.

Market Dynamics

The market for life science analytics is expected to grow significantly during the forecast period. Government initiatives to develop and deploy healthcare IT globally is the principal drivers for the market growth. For instance, in 58th World Health Assembly, the World Health Organization (WHO) urged member states to follow few strategic actions to promote healthcare IT. One of them was to develop long-term action plan for deployment of healthcare IT services in various areas of healthcare, and to develop the infrastructure for information and communication technologies with universal access. Another one was to establish and implement national electronic public health information system, which would improve the capacity of surveillance and get rapid response to disease and public health emergencies. However, data privacy issues, financial restrictions, and lack of skilled professionals are few factors, which might obstruct the growth of market in the long run.

Market Classification and Overview

The life science analytics market is segmented on the basis of type, mode of delivery, end-user and geography. Based on type, the market is segmented into descriptive, prescriptive, and predictive. Prescriptive analytics is anticipated to grow at the fastest CAGR. Such analytics help healthcare organizations to effectively respond to challenges and consequently, convert them into opportunities to drive competitive advantage.

Based on mode of delivery, the life science analytics market is categorized into on-premise and on-demand. On-demand mode of delivery is capturing the largest market share as the data is stored on safe, updated, backed-up daily enterprise-class servers in an extremely secure data centers. Hence, the user does not have to be worried about any technical issues. These factors together will boost the growth of market segment during the forecast period.

Regional Overview

Regionally, the market for life science analytics is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa (MEA). North America is dominating the global market. Increasing incidence of diseases, greater demand for effective and affordable treatment options, and increasing demand to reduce the healthcare cost are few high impact-rendering drivers for the market in North America. However, Asia-Pacific is expected to grow at the fastest CAGR owing to low manufacturing cost, supportive government initiatives to improve medical infrastructure and economic developments in this region.

Report Coverage

Market

Life Science Analytics Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Type, Mode of Delivery, End-user, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

SAS Institute Inc., TAKE Solutions, and SCIO Health Analytics, Quintiles, Inc., Accenture, Cognizant, Wipro Limited, Oracle Corporation, IBM Corporation, MaxisIT, Inc., are the key players in the life science analytics market. These players have undertaken mergers and acquisitions as one of their key strategies in order to maximize their share in the global market.

Market Segmentation

Market By Type

·         Descriptive

·         Prescriptive

·         Predictive

Market By Mode of Delivery

·         On-premise

·         On-demand

Market By End-user

·         Pharmaceutical Companies

·         Biotechnology Companies

·         Medical Devices Companies

·         Research Centers

·         Others

Market By Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Australia

o   Rest of Asia-Pacific

·         Latin America

o   Brazil

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary